Related Experiment Video
Updated: Jun 4, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
Published on: December 26, 2017
Macrophages from IBD patients exhibit defective tumour necrosis factor-α secretion but otherwise normal or augmented
Nair Campos1, Fernando Magro, Ana Rita Castro
1CEBIMED - Biomedicine Research Center, Health Sciences Faculty, University Fernando Pessoa, Porto, Portugal.
Abstract:
Defects in macrophage function have been implicated in the establishment of Crohn's disease (CD). However, the response of macrophages from CD patients to live bacteria, particularly Mycobacterium avium subsp. paratuberculosis (MAP), has not been addressed. Considering MAP has long been associated to CD, our objective was to assess whether macrophages from CD patients showed impaired inflammatory response to infection by MAP comparing to M. avium subsp. avium (MA) and other live intestinal commensal bacteria. Human peripheral blood monocyte-derived macrophages were obtained from CD patients, ulcerative colitis (UC) patients and controls. Following in vitro infection with MAP, MA, Escherichia coli or Enterococcus faecalis, cytokine levels and cell surface receptor expression were evaluated at different time points. Macrophages from CD patients showed impaired TNF-α secretion in response to bacterial challenge, but augmented IL-23 secretion and preserved IL-12 secretion and CD-40 expression. In addition, CD macrophages showed low IL-10 secretion. Macrophages from IBD patients showed increased expression of TLR-2 and -4, unaffected by infection. Differences in cytokine secretion observed after bacterial challenge were not MAP-specific, as other bacteria (E. coli and MA) showed similar effects. Macrophages from UC patients showed a less compromised TNF-α synthesis in response to mycobacterial infection than CD macrophages, with increased constitutive IL-12 secretion, and preserved IL-10 secretion. The increased IL-23 levels in response to infection and decreased IL-10 production observed in macrophages from CD patients may contribute to the inflammatory exacerbation observed in those patients.
Insights
Macrophages from Crohn's disease (CD) patients exhibit altered inflammatory responses to gut bacteria. CD patient macrophages show reduced TNF-α and IL-10, but increased IL-23, potentially worsening inflammation.
Area of Science:
- Immunology
- Gastroenterology
- Microbiology
Background:
- Macrophage dysfunction is linked to Crohn's disease (CD) pathogenesis.
- The response of CD patient macrophages to specific bacteria like Mycobacterium avium subsp. paratuberculosis (MAP) remains unclear.
Purpose of the Study:
- To investigate the inflammatory response of macrophages from CD patients upon infection with MAP, M. avium subsp. avium (MA), and commensal bacteria.
- To compare these responses with those of macrophages from ulcerative colitis (UC) patients and healthy controls.
Main Methods:
- Human peripheral blood monocyte-derived macrophages were isolated from CD patients, UC patients, and controls.
- Macrophages were infected in vitro with MAP, MA, Escherichia coli, or Enterococcus faecalis.
- Cytokine levels (TNF-α, IL-23, IL-12, IL-10) and cell surface receptor expression (CD-40, TLR-2, TLR-4) were measured.
Main Results:
- CD patient macrophages displayed impaired TNF-α secretion but augmented IL-23 and preserved IL-12 secretion and CD-40 expression after bacterial challenge.
- Macrophages from CD patients showed significantly lower IL-10 secretion.
- These altered cytokine profiles were not specific to MAP, occurring with other tested bacteria.
- UC patient macrophages showed less compromised TNF-α synthesis and preserved IL-10 secretion compared to CD macrophages.
Conclusions:
- Macrophages from CD patients exhibit a distinct inflammatory profile characterized by reduced TNF-α and IL-10, and increased IL-23 production in response to bacterial stimuli.
- This dysregulated immune response in CD macrophages may contribute to the chronic inflammation characteristic of the disease.
- The findings highlight potential therapeutic targets related to macrophage function in Crohn's disease management.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease II: Ulcerative Colitis
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Chronic Inflammation: Introduction
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...

